Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy

British Journal of Dermatology

Volumn 153, Issue 3, 2005, Pages 506-513

  Selleri, S ^a   Arnaboldi, F ^a   Palazzo, M ^a   Hussein, U ^a   Balsari, A ^a   Rumio, Cristiano ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alopecia; Bulge; Caveolae; Chemotherapy; Doxorubicin; Drug resistance

Indexed keywords

BETA CATENIN; CAVEOLIN 1; DOXORUBICIN;

ALOPECIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL FUNCTION; CELL MEMBRANE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; HAIR FOLLICLE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALOPECIA; ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; BIOLOGICAL MARKERS; CAVEOLIN 1; CAVEOLINS; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DOXORUBICIN; DRUG RESISTANCE; HAIR FOLLICLE; HAIR REMOVAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MULTIPOTENT STEM CELLS; TRANS-ACTIVATORS;

EID: 24344500281     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06746.x     Document Type: Article

References (44)

1. Palade CE. Fine structure of blood capillaries. J Appl Phys 1953; 24:1424.
2. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1955; 1:445-58.
3. Oh P, Schnitzer JE. Segregation of heterotrimeric G proteins in cell surface microdomains: Gq binds caveolin to concentrate in caveolae whereas Gi and Gs target lipid rafts by default. Mol Biol Cell 2001; 12:685-98.
4. Liu J, Oh P, Horner T et al. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem 1997; 272:7211-22.
5. Liu P, Ying Y, Ko YG, Anderson RG. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J Biol Chem 1996; 271:10299-303.
6. Rizzo V, Sung A, Oh P, Schnitzer JE. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J Biol Chem 1998; 273:26323-9.
7. Rizzo V, McIntosh DP, Oh P, Schnitzer JE. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem 1998; 273:34724-9.
8. Rothberg KG, Heuser JE, Donzell WC et al. Caveolin, a protein component of caveolae membrane coats. Cell 1992; 68:673-82.
9. Park H, Go YM, Darji R et al. Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase. Am J Physiol Heart Circ Physiol 2000; 278:1285-93H.
10. Galbiati F, Volonte D, Gil O et al. Expression of caveolin 1 and 2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 1998; 95:10257-62.
11. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994; 127:1217-32.
12. Montesano R, Roth J, Robert A, Orci L. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 1982; 296:651-3.
13. Schnitzer JE, Oh P. Aquaporin-1 in plasma membrane and caveolae provides mercury-sensitive water channels across lung endothelium. Am J Physiol 1996; 270:H416-22.
14. Schnitzer JE. Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Del Rev 2001; 49:265-80.
15. Parat MO, Anand-Apte B, Fox PL. Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell 2003; 14:3156-68.
16. Liscovitch M, Lavie Y. Multidrug resistance: a role for cholesterol efflux pathways? Trends Biochem Sci 2000; 25:530-4.
17. Lavie Y, Fiucci G, Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 1998; 273:32380-3.
18. Lavie Y, Liscovitch M. Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences. Glycoconj J 2000; 17:253-9.
19. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61:1329-37.
20. Cece R, Cazzaniga S, Morelli D et al. Apoptosis of hair follicle cells during doxorubicin-induced alopecia in rats. Lab Invest 1996; 75:601-9.
21. Selleri S, Arnaboldi F, Vizzotto L, Balsari A. Epithelium-mesenchyme compartment interaction and oncosis on chemotherapy induced hair damage. Lab Invest 2004; 84:1404-17.
22. Muller-Rover S, Handjiski B, van der Veen C et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001; 117:3-15.
23. Liu Y, Lyle S, Yang Z, Cotsarelis G. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J Invest Dermatol 2003; 121:963-8.
24. Nusse R. WNT targets. Repression and activation. Trends Genet 1999; 15:1-3.
25. Alonso L, Fuchs E. Stem cells in the skin: waste not, Wnt not. Genes Dev 2003; 17:1189-200.
26. Paus R, Handjiski B, Eichmuller S, Czarnetzki BM. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone. Am J Pathol 1994; 144:719-34.
27. Ohnemus U, Unalan M, Handjiski B, Paus R. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage. J Invest Dermatol 2004; 122:7-13.
28. Sun TT, Cotsarelis G, Lavker RM. Hair follicular stem cells: the bulge-activation hypothesis. J Invest Dermatol 1991; 96:77-85.
29. Wilson C, Cotsarelis G, Wei ZG et al. Cells within the bulge region of mouse hair follicle transiently proliferate during early anagen: heterogeneity and functional differences of various hair cycles. Differentiation 1994; 55:127-36.
30. Razani B, Woodman SE, Lisanti MP. Caveolae: from, cell biology to animal physiology. Pharmacol Rev 2002; 54:431-67.
31. Cho KA, Ryu SJ, Park JS et al. Senescent phenotype can be reversed by reduction of caveolin status. J Biol Chem 2003; 278:27789-95.
32. Galbiati F, Volonte D, Engelman JA et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998; 17:6633-48.
33. Razani B, Altschuler Y, Zhu L et al. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry 2000; 39:13916-24.
34. Capozza F, Williams TM, Schubert W et al. Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am J Pathol 2003; 162:2029-39.
35. Gat U, Das Gupta R, Degenstein L, Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 1998; 95:605-14.
36. Huelsken J, Vogel R, Erdmann B et al. β-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001; 105:533-45.
37. Galbiati F, Volonte D, Brown AM et al. Caveolin-1 expression inhibits Wnt/β-catenin/Lef-1 signaling by recruiting β-catenin to caveolae membrane domains. J Biol Chem 2000; 275:23368-77.
38. Demeule M, Jodoin J, Gingras D, Beliveau R. P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett 2000; 466:219-24.
39. Furukawa T, Kubota T, Murata H et al. Antitumor spectra of anthracyclines against gastric cancer tissues obtained from surgical specimens with reference to P-glycoprotein expression. J Surg Oncol 1998; 69:173-7.
40. Tritton TR. Cell surface actions of adriamycin. Pharmacol Ther 1991; 49:293-309.
41. Lind DS, Kontaridis MI, Edwards PD et al. Nitric oxide contributes to adriamycin's antitumor effect. J Surg Res 1997; 69:283-7.
42. Joshi P, Vig PJ, Veerisetty V et al. Increase in brain nitric oxide synthase activity in daunorubicin-treated rats. Pharmacol Toxicol 1996; 78:99-103.
43. Kalivendi SV, Kotamraju S, Zhao H et al. Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calcium. J Biol Chem 2001; 276:47266-76.
44. Carver LA, Schnitzer JE. Caveolae: mining little caves for new cancer targets. Nat Rev Cancer 2003; 3:571-81.